{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-034401","form_type":"8-K","ticker":"GYRE","cik":"0001124105","company_name":"GYRE THERAPEUTICS, INC.","filed_at":"2026-08-26T13:00:44+00:00","discovered_at":"2026-08-26T13:02:31.361323+00:00","generated_at":"2026-08-26T13:02:48.849789+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Gyre posts updated corporate presentation; no financial or clinical data disclosed","bullets":["On Aug 26, 2026, Gyre Therapeutics, Inc. posted an updated corporate presentation to its website (Exhibit 99.1, dated August 2026).","Presentation titled 'Building A New Protein Degrader Company For Unmet Medical Needs'; no financial or clinical data appear in the provided text.","The exhibit text is truncated at a disclaimer page; no revenue, EPS, pipeline, or guidance figures are visible.","No forward-looking statements, financial metrics, or clinical updates are included in the excerpt furnished."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-034401","json":"https://secwatch.observer/filing/0001140361-26-034401.json","markdown":"https://secwatch.observer/filing/0001140361-26-034401.md","text":"https://secwatch.observer/filing/0001140361-26-034401.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126034401/0001140361-26-034401-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1124105/000114036126034401/ef20081104_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-26T13:02:48.849789+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}